Work

Abstract P6-11-09: A preclinical study to demonstrate the utility of fulvestrant and MLN0128 combination against HR+ and HER2+ breast cancer

Year: 2015

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs14-p6-11-09

Authors: Shang Victoria Wu, Hannah Lu, Masaya Kai, Noriko Kanaya, Thenhang Luu, Courtney Vito, Laura Kruper, Joanne Mortimer, Shiuan Chen

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2221687828

Cites:

Cited by:

Related to: 10